#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiac failure acute Becker's muscular dystrophy Non-Hodgkin's lymphoma refractory Crigler-Najjar syndrome Biotinidase deficiency Multiple system atrophy Transferrin decreased Retinopathy of prematurity Nephrotic syndrome Phenylketonuria Synovitis Skin angiosarcoma Paroxysmal nocturnal haemoglobinuria Pyogenic sterile arthritis pyoderma gangrenosum and acne syndrome Neuroendocrine carcinoma More trials…

    Learn about Rare Diseases

    Basal cell naevus syndrome – Basic Information Inclusion body myositis – Life with Disease Primary mediastinal large B-cell lymphoma – Basic Information Medulloblastoma recurrent Phenylketonuria – Diagnostics Angelman’s syndrome – Basic Information Cystic fibrosis lung – Trials in Disease Mantle cell lymphoma stage II – Life with Disease Primary immunodeficiency syndrome – Basic Information Primary mediastinal large B-cell lymphoma More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ambrosia Artemisiifolia (302) ZIRCONIUM (89ZR) GIRENTUXIMAB Aprepitant Hypromellose Osimertinib Resiniferatoxin Bepranemab Isoleucine Darbepoetin Alfa Minoxidil Tovinontrine Oleclumab Cobamamide Betamethasone Valerate Mavacamten Festuca Rubra Pollen Pal1-15 Acetate Patisiran Piromelatine Medi0618 More therapies…

    Learn about Your Condition

    Hyponatraemia Hypertonic bladder Gaucher's disease type III Ovarian epithelial cancer Stargardt's disease Dermatitis atopic Acquired haemophilia Haemorrhagic stroke Cardiac failure acute Osteomyelitis acute Schizoaffective disorder Pelvic venous thrombosis Diabetic foot infection Injection site pain Diabetic retinal oedema More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Hormone receptor positive HER2 negative breast cancer

  • Study on Alpelisib and Fulvestrant for Patients with HR+, HER2- Metastatic Breast Cancer

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Breast cancer metastatic
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Alpelisib
    Croatia

  • Gedatolisib plus drug combination for HR‑positive, HER2‑negative advanced breast cancer patients whose disease progressed after CDK4/6 inhibitor therapy

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    • Breast cancer
    • Hormone receptor positive breast cancer
    Investigated Drugs:
    • Alpelisib
    • Gedatolisib
    • Palbociclib
    Austria Belgium Bulgaria Czechia France Germany +6

  • Study on the Effects of Ribociclib and Endocrine Therapy for Patients with HR-Positive, HER2-Negative Early Breast Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Anastrozole
    • Exemestane
    • Goserelin
    Germany Portugal

  • Study of Elacestrant and Ribociclib for Patients with Endocrine-Responsive HER2-Negative Early Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Drugs:
    • Elacestrant
    • Anastrozole
    • Exemestane
    Austria Germany

  • Study on Abemaciclib, Letrozole, and Fulvestrant for Patients with Advanced HR-positive/HER2-negative Breast Cancer

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Letrozole
    • Fulvestrant
    • Paclitaxel
    Italy Portugal Spain

  • Study on Niraparib for Patients with HER2-Negative BRCA-Mutated or Triple-Negative Breast Cancer with Molecular Disease Detected by ctDNA

    Not recruiting

    3 1
    Investigated Diseases:
    • Triple negative breast cancer
    • Hormone receptor positive HER2 negative breast cancer
    Investigated Drugs:
    • Niraparib Tosilate Monohydrate
    Italy The Netherlands Poland Spain
Previous Page
1 … 4 5 6 7 8 … 10
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!